[Suppurative Thrombophlebitis of the Posterior Neck Caused by Streptococcus constellatus: A Case Report and Literature Review].


Journal

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
ISSN: 1347-5231
Titre abrégé: Yakugaku Zasshi
Pays: Japan
ID NLM: 0413613

Informations de publication

Date de publication:
2022
Historique:
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 19 2 2022
Statut: ppublish

Résumé

We report a rare case of suppurative thrombophlebitis of the posterior neck caused by Streptococcus constellatus. A 69-year-old female patient was admitted to the hospital with neck pain and fever, which had persisted for 16 days prior to hospitalization. On day 1 (day of admission), blood cultures (later identifying S. constellatus) were performed, and ceftriaxone (CTRX) IV (2 g SID) was started. On day 3, suppurative thrombophlebitis of the posterior neck was diagnosed by CT scan. The antimicrobials were changed from CTRX to ampicillin/sulbactam IV (12 g QID) to guard against the possibility of complicated infection with Fusobacterium spp. or Prevotella spp. On day 17, a CT scan revealed that the thrombus remained. Therefore, oral edoxaban (30 mg SID) was started. On day 27, the patient was discharged after her medication was changed to oral amoxicillin/clavulanate (1500 mg/375 mg TID). On day 33, the amoxicillin/clavulanate was changed to oral cefaclor (1500 mg TID) and edoxaban was discontinued due to itching. On day 45, the course of cefaclor was completed. The patient went on to follow an uneventful course with no relapses or complications for two years since the conclusion of treatment. These results suggest that when a patient presents with persistent neck pain accompanied by fever, suppurative thrombophlebitis of the posterior neck should be considered. In antimicrobial therapy, the treatment could be switched from intravenous to oral. In addition, direct-acting oral anticoagulants may be an alternative to other forms of anticoagulants.

Identifiants

pubmed: 35110455
doi: 10.1248/yakushi.21-00179
doi:

Substances chimiques

Anti-Bacterial Agents 0
edoxudin 15ZQM81Y3R
sultamicillin 65DT0ML581
Cefaclor 69K7K19H4L
Amoxicillin-Potassium Clavulanate Combination 74469-00-4
Ampicillin 7C782967RD
Sulbactam S4TF6I2330
Deoxyuridine W78I7AY22C

Types de publication

Journal Article Review

Langues

jpn

Sous-ensembles de citation

IM

Pagination

189-193

Auteurs

Keisuke Takada (K)

Department of Pharmacy, Yokohama General Hospital.

Mitsuchika Nakamura (M)

Department of Internal Medicine, Yokohama General Hospital.

Masaru Samura (M)

Department of Pharmacy, Yokohama General Hospital.

Junki Inoue (J)

Department of Pharmacy, Yokohama General Hospital.

Naoki Hirose (N)

Department of Pharmacy, Yokohama General Hospital.

Takenori Kurata (T)

Department of Pharmacy, Yokohama General Hospital.

Humio Nagumo (H)

Department of Pharmacy, Yokohama General Hospital.

Junichi Ishii (J)

Department of Pharmacy, Yokohama General Hospital.

Sakura Koshioka (S)

Department of Pharmacy, Yokohama General Hospital.

Koji Tanikawa (K)

Department of Pharmacy, Yokohama General Hospital.

Hiroyuki Kunishima (H)

Department of Infectious Diseases, St. Marianna University School of Medicine Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH